Suppr超能文献

新生儿在表面活性剂替代治疗前后呼吸系统的顺应性。

Compliance of the respiratory system in newborn infants pre- and postsurfactant replacement therapy.

作者信息

Kelly E, Bryan H, Possmayer F, Frndova H, Bryan C

机构信息

Department of Pediatrics, Mount Sinai Hospital, University of Toronto, Ontario, Canada.

出版信息

Pediatr Pulmonol. 1993 Apr;15(4):225-30. doi: 10.1002/ppul.1950150408.

Abstract

Surfactant administration causes a rapid and dramatic improvement in gas exchange, but paradoxically, studies have failed to show an improvement in the mechanical properties of the lung. We have measured dynamic and static (passive flow-volume technique) compliance before and after a single dose of bovine lipid extract surfactant in 22 premature infants with RDS. This had no effect on the measured dynamic compliance. In contrast, surfactant significantly increased static compliance from 0.41 +/- 0.02 to 0.55 +/- 0.04 mL/cm H2O/kg. This improvement was the result of a substantial recruitment of lung volume after surfactant administration. This led us to reduce ventilator pressures, which produced an increase in both dynamic and static compliance, but did not recruit additional volume. We conclude that surfactant causes a substantial increase in static compliance due to volume recruitment, which is consistent with reports of increase in the measured FRC. However, despite this improvement, the compliance is still below our normal range.

摘要

表面活性剂给药可使气体交换迅速且显著改善,但矛盾的是,研究未能显示肺的力学特性有所改善。我们在22例患有呼吸窘迫综合征(RDS)的早产儿中,测量了单次剂量牛肺脂质提取物表面活性剂给药前后的动态和静态(被动流速 - 容量技术)顺应性。这对所测量的动态顺应性没有影响。相比之下,表面活性剂使静态顺应性从0.41±0.02显著增加至0.55±0.04 mL/cm H₂O/kg。这种改善是表面活性剂给药后肺容量大量复张的结果。这使我们降低了呼吸机压力,从而使动态和静态顺应性均增加,但并未复张额外的容量。我们得出结论,表面活性剂由于容量复张导致静态顺应性大幅增加,这与所测量的功能残气量(FRC)增加的报道一致。然而,尽管有这种改善,顺应性仍低于我们的正常范围。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验